期刊文献+

不同年龄健康女性血清性激素和抗酒石酸酸性磷酸酶的变化 被引量:2

Age related changes of serum sex hormone levels and tartrate-resistant acid phosphatase activity in healthy women
下载PDF
导出
摘要 目的 :研究女性血清性激素和抗酒石酸酸性磷酸酶 (TRACP)水平随年龄的变化 ,为骨质疏松症的基础与临床研究提供参数。方法 :测量 2 36例 2 3~ 5 3岁绝经前 (按年龄分为 3组 ,每组间隔 10年 )和 91例 4 8~ 71岁绝经后健康女性志愿者血清黄体生成素 (LH)、卵泡刺激素 (FSH)、雌二醇 (E2 )、孕酮 (P)水平及TRACP活性。结果 :绝经前各年龄组比较 ,仅FSH水平在绝经前第 3组妇女中明显升高 (P <0 .0 5 ) ;绝经后与绝经前组比较 ,FSH ,LH和TRACP明显升高 (P <0 .0 1) ,而雌二醇和孕酮明显降低 (P <0 .0 1) ,且与TRACP呈显著负相关 (r分别为 - 0 .4 1和 - 0 .37,P <0 .0 1)。结论 :女性绝经后 ,雌孕激素缺乏 ,导致FSH ,LH升高 ,同时骨吸收加快 。 Objective To study the changes of serum sex hormone levels and tartrate resistant acid phosphatase (TRACP) activity in healthy women of different ages, and to provide parameters for basic and clinical research of osteoporosis. Methods Serum sex hormone (FSH, LH, E 2, P) levels and TRACP activity were measured in 236 premenopausal healthy women aged 23~53 years and divided into 3 groups, and in 91 postmenopausal healthy women aged 48~71 years. Results Except serum FSH levels which were significantly higher in the third group than those of the other groups in premenopausal healthy women (P<0.05), no significant difference in sex hormone levels and TRACP activity was found among the 3 groups; the postmenopausal group showed a significant increase in serum FSH, LH levels and TRACP activity and a significant decrease in serum E 2, P levels, compared with the premenopausal groups (P<0.01). There was a negative correlation between E 2, P levels and TRACP activity in the postmenopausal women (r=-0.41 and -0.37, respectively , P<0.01). Conclusion Postmenopausal diminution of E 2, P results in an increase of serum FSH and LH levels, and may bring about an increase of bone resorption, which results in the increase of TRACP activity.
出处 《湖南医科大学学报》 CSCD 北大核心 2002年第2期127-129,共3页 Bulletin of Hunan Medical University
关键词 年龄 健康女性 血清性激素 抗酒石酸酸性磷酸酶 TRACP 骨质疏松 骨吸收 sex hormones tartrate resistant acid phosphatase * menopause
  • 相关文献

参考文献9

  • 1王洪复,高建军.骨吸收机制[J].中国骨质疏松杂志,2000,6(3):76-78. 被引量:4
  • 2Scarnecchia L, Minsola S, Pacitti MT, et al. Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover[J]. Scand J Clin Lab Invest, 1991,51:517-523.
  • 3Lau K-HW, Onishi T, Wergedal JE, et al. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption[J]. Clin Chem,1987,33:458-462.
  • 4Pacifici R. Cytokines and pathogenesis of postmenopausal osteoporosis[J]. J Bone Miner Res, 1996,11:1043-1045.
  • 5侯静,蔡桂英,杨霞,赵玉华.正常人血清抗酒石酸盐酸性磷酸酶活性的观察[J].中国骨质疏松杂志,1999,5(1):43-45. 被引量:1
  • 6莫朝晖. 更年期综合征, 廖二元,超楚生主编. 内分泌学[M].北京:人民卫生出版社,2001.1233-1238.
  • 7权金星,李茂欣.绝经后骨质疏松的分子机理研究进展[J].中华妇产科杂志,2000,35(12):754-756. 被引量:21
  • 8Ikegami A, Inoue S, Hosoi T, et al. Cell cycle dependent expression and function of estrogen receptor in human osteolastic cells[J].Endocrinology,1994.135:782-789.
  • 9John A.The endocrinology nad biochemistry of osteoprosis[J].Osteoporosis.1997.15:56-58.

二级参考文献43

  • 11,Burger EH,van der Meer JWM,Nijweide PJ.Osteoclast formation from mononuclear phagocytes.role of bone-forming cells.J Cell Biol,1984,99:1901-1906.
  • 22,Takahashi N,Yamana M,Yoshiki S,et al.Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.Endocrinology,1988,122:1373-1380.
  • 33,Takahashi N,Udagawa N,Akatsu T,et al.Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells.Endocrinology,1991,128:1792-1796.
  • 44,Takahashi N,Udagawa N,Akatsu T,et al.Role of colony-stimulating factors in osteoclast development.J Bone Miner Res,1991,6:977-985.
  • 55,Fenton AJ,Martin TJ,Nicholson GC.Long-term culture of disaggregated rat osteoclasts:Inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrp(107-199).J Cell Physiol,1993,155:1-7.
  • 66,Jimi E,Nakamura I,Amano H,et al.Osteoclast function is activated by osteoblastic cell through a mechanism involving cell-to-cell contact.Endocrinology,1996,137:2187-2190.
  • 77,Takahashi N,Udagawa N,Suda T. A new member of tumor necrosis factor ligand family,ODF/OPGL/TRANCE/RANKL,regulates osteoclast differentiation and function.Biochem Biophys Res Commun,1999,256(3):449-455.
  • 88,Yamamoto M,Murakami T,Nishikawa M,et al.Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat.Endocrinology,1998,139(9):4012-4015.
  • 99,Greenfield EM,Bi Y,Miyauchi A.Regulation of osteoclast activity.Life Sci,1999,65(11):1087-1102.
  • 1010,Horwood NJ,Elliott J,Martin TJ,et al.Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells.Endocrinology,1998,139(11):4743-4746.

共引文献22

同被引文献30

  • 1张铭.乳腺癌患者血清CA15-3的检测及临床意义[J].医学研究生学报,1999,12(1):11-13. 被引量:2
  • 2周倩,刘晓瑷.选择性雌激素受体调节剂雷洛昔芬的临床研究进展[J].国外医学(计划生育分册),2004,23(3):140-143. 被引量:2
  • 3金丽,罗丽娜.游泳加中药淫羊藿综合疗法对去势大鼠骨代谢生化指标的作用[J].山东体育学院学报,2006,22(6):53-55. 被引量:7
  • 4中华人民共和国科学技术部.关于善待实验动物的指导性意见.2006.09-30
  • 5Albright F,Smith PH,Rchardson AM.Postmenopausal osteoporosis:Its feature.JAMA.1941 ;116:2465-2476.
  • 6Turner CH,Sato M,Bryant HU.Raloxifene preserves bone strength and bone mass in ovariectomized rats.Endocrinology.1994;135(5):2001-2005.
  • 7Black LJ,Sato M,Rowley ER,et al.Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.J Clin Invest.1994;93(1):63-69.
  • 8Hansdóttir H,Franzson L,Prestwood K,et al.The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities.J Am Geriatr Soc.2004;52(5):779-783.
  • 9Nakamura T,Liu JL,Morii H,et al.Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis.J Bone Miner Metab.2006;24(5):414-418.
  • 10Giavaresi G,Fini M,Gnudi S,et al.The femoral distal epiphysis of ovariectomized rats as a site for studies on osteoporosis:structural and mechanical evaluations.Clin Exp Rheumatol.2002;20(2):171-178.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部